DOUBLE LATIN SQUARE STUDY TO DETERMINE VARIABILITY AND RELATIVE BIOAVAILABILITY OF METHYLPREDNISOLONE

被引:10
作者
ALBERT, KS
BROWN, SW
DESANTE, KA
DISANTO, AR
STEWART, RD
CHEN, TT
机构
[1] Upjohn Company, Kalamazoo, Michigan
关键词
Bioavailability—commercial methylprednisolone preparations; Glucocprticoids—methylprednisolone; bioavailability; tablet variability; commercial preparations; Latin square study; Methylprednisolone—bioavailability;
D O I
10.1002/jps.2600681031
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The variability and relative bioavailability of methylprednisolone tablets were evaluated utilizing a double Latin square crossover design in which each of 20 subjects was given four of five treatments. Three different lots of methylprednisolone tablets exhibited virtually identical absorption, with similar ranges and coefficients of variation of some selected bioavailability parameters indicative of lot‐to‐lot uniformity in bioavailability. Within‐lot and between‐lot uniformities in bioavailability also were similar, suggesting that the observed variability in serum methylprednisolone levels was not due to manufacturing process variables. With respect to intra‐ versus intersubject variability, no differences were found for the absorption rate or terminal half‐life. In contrast, between‐subject variability associated with extent of absorption was greater than that within subjects. Relative to an aqueous suspension, methylprednisolone tablets were fully bioavailable. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:1312 / 1316
页数:5
相关论文
共 7 条
[1]   PROBLEMS IN THE ANALYSIS OF GROWTH AND WEAR CURVES [J].
BOX, GEP .
BIOMETRICS, 1950, 6 (04) :362-389
[2]  
BUTLER K, 1973, REV CAN BIOL EXPTL, V32, P53
[3]   APPROXIMATE SIGNIFICANCE LEVELS OF BEHRENS-FISHER TEST [J].
COCHRAN, WG .
BIOMETRICS, 1964, 20 (01) :191-&
[4]   RADIOIMMUNOASSAY FOR METHYLPREDNISOLONE (MEDROL) [J].
COLBURN, WA ;
BULLER, RH .
STEROIDS, 1973, 22 (05) :687-698
[5]  
DISANTO AR, 1976, INT J CLIN PHARM BI, V13, P220
[6]  
STROLL RG, 1978, CLIN PHARMACOL THER, V23, P131
[7]  
1977, FED REG 0107, P1624